April Stanley brings over a decade of multifaceted experience in the biopharmaceutical industry to her roles as Senior Scientific Research Director and M&A Advisor. Her expertise spans therapeutics, manufacturing, medical devices, and computational biology. April’s background in venture investments and corporate board participation has equipped her with a unique perspective on strategic growth and investment opportunities, positioning her to offer invaluable advice and insights for informing client strategy. April holds a master’s degree in Microbiology and an MBA from the University of Illinois.